FDA Reports to Congress on Regulatory Science Achievements

Drug Industry Daily
A A
In a regulatory science update to Congress, the FDA cited its successes with the use of specialized consortia and improvements in clinical evaluation.

To View This Article:

Login

Subscribe To Drug Industry Daily